Low molecular weight cyclin E is associated with p27-resistant, high-grade, high-stage and invasive bladder cancer

Expression of low molecular weight (LMW) isoforms of cyclin E is a strong predictor of poor outcome in patients with breast cancer. The purpose of this study was to examine the expression of full-length and LMW cyclin E in bladder cancer cell lines and patient tumors. We used western blotting, immunoprecipitation and kinase assays to examine the expression and activity of key cell cycle-regulatory proteins in various human bladder cell lines, both tumorigenic and non-tumorigenic. We also analyzed cyclin E expression, kinase activity and immune complex binding partners in 43 tissue samples from grade 2 and 3 transitional cell carcinomas. Cyclin E was overexpressed and LMW isoforms were present only in bladder cancer cells. Overexpression of LMW isoforms of cyclin E and increased cyclin E kinase activity were both significantly associated with tumorigenicity of the bladder cell lines (p = 0.005 and 0.022, respectively). Binding of the cyclin-dependent kinase inhibitors p21 and p27 to LMW cyclin E did not inhibit the kinase activity of cyclin E and cyclin-dependent kinase 2 in primary tumor samples overexpressing LMW cyclin E. Full-length and LMW cyclin E were significantly overexpressed in grade 3 tumors compared with grade 2 tumors (p = 0.004). Finally, LMW cyclin E levels were significantly associated with a non-papillary growth pattern (p = 0.031) and invasiveness (p = 0.021) of the bladder tumors and poor overall survival (p = 0.06). These results suggest that LMW cyclin E can be used as a new prognostic marker for bladder cancer.

[1]  R. Agami,et al.  MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progression , 2011, Cell cycle.

[2]  A. Kenney,et al.  p27(Kip1), a double-edged sword in Shh-mediated medulloblastoma: Tumor accelerator and suppressor. , 2010, Cell cycle.

[3]  K. Hunt,et al.  Low molecular weight cyclin E overexpression shortens mitosis, leading to chromosome missegregation and centrosome amplification. , 2010, Cancer research.

[4]  B. Clurman,et al.  Cyclin E in normal and neoplastic cell cycles , 2005, Oncogene.

[5]  J. J. van den Oord,et al.  The low molecular weight cyclin E isoforms augment angiogenesis and metastasis of human melanoma cells in vivo. , 2005, Cancer research.

[6]  R. Millikan,et al.  Focus on bladder cancer. , 2004, Cancer cell.

[7]  Takayuki Nojima,et al.  Induction of Centrosome Amplification and Chromosome Instability in Human Bladder Cancer Cells by p53 Mutation and Cyclin E Overexpression , 2004, Cancer Research.

[8]  S. Tucker,et al.  Tumor-specific low molecular weight forms of cyclin E induce genomic instability and resistance to p21, p27, and antiestrogens in breast cancer. , 2004, Cancer research.

[9]  I. Bedrosian,et al.  Cyclin E deregulation alters the biologic properties of ovarian cancer cells , 2004, Oncogene.

[10]  Carlo Rago,et al.  Inactivation of hCDC4 can cause chromosomal instability , 2004, Nature.

[11]  A. Jemal,et al.  Cancer Statistics, 2004 , 2004, CA: a cancer journal for clinicians.

[12]  J. Kononen,et al.  Cyclin E overexpression and amplification in human tumours , 2003, The Journal of pathology.

[13]  K. Keyomarsi,et al.  Cyclin E and Its Low Molecular Weight Forms in Human Cancer and as Targets for Cancer Therapy , 2003, Cancer biology & therapy.

[14]  L. Santos,et al.  Expression of cell-cycle regulatory proteins and their prognostic value in superficial low-grade urothelial cell carcinoma of the bladder. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[15]  Michele Pagano,et al.  Deregulated degradation of the cdk inhibitor p27 and malignant transformation. , 2003, Seminars in cancer biology.

[16]  E. Uro-Coste,et al.  Expression of p27(Kip1) in bladder cancers: immunohistochemical study and prognostic value in a series of 95 cases. , 2002, Cancer letters.

[17]  Isabelle Bedrosian,et al.  Cyclin E and survival in patients with breast cancer. , 2002, The New England journal of medicine.

[18]  Carlos L. Arteaga,et al.  PKB/Akt mediates cell-cycle progression by phosphorylation of p27Kip1 at threonine 157 and modulation of its cellular localization , 2002, Nature Medicine.

[19]  S. Reed,et al.  hCDC4 gene mutations in endometrial cancer. , 2002, Cancer research.

[20]  A. Lenferink,et al.  ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways. , 2001, Cancer research.

[21]  Mollianne J. McGahren,et al.  Tumor-Specific Proteolytic Processing of Cyclin E Generates Hyperactive Lower-Molecular-Weight Forms , 2001, Molecular and Cellular Biology.

[22]  Cody Schrank,et al.  American Cancer Society , 2005 .

[23]  S. Elledge,et al.  Phosphorylation-Dependent Ubiquitination of Cyclin E by the SCFFbw7 Ubiquitin Ligase , 2001, Science.

[24]  R. Weinberg,et al.  Disruption of TGF-β growth inhibition by oncogenic ras is linked to p27Kip1 mislocalization , 2000, Oncogene.

[25]  W. Schulz,et al.  Cyclin-dependent kinase inhibitor P27(KIP1) is expressed preferentially in early stages of urothelial carcinoma. , 2000, Urology.

[26]  T Hardmeier,et al.  High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer. , 2000, The American journal of pathology.

[27]  P. Korkolopoulou,et al.  Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1. , 2000, Human pathology.

[28]  A. Koff,et al.  Cell-cycle inhibitors: three families united by a common cause. , 2000, Gene.

[29]  A. Borkowski,et al.  Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival. , 1999, The American journal of pathology.

[30]  Tait,et al.  Expression of Transforming Growth Factor-beta Receptors and Related Cell-Cycle Components in Transitional-Cell Carcinoma of the Bladder. , 1999, Molecular urology.

[31]  C. Bucana,et al.  Isolation and characterization of metastatic variants from human transitional cell carcinoma passaged by orthotopic implantation in athymic nude mice. , 1995, The Journal of urology.

[32]  E. Lees,et al.  Cyclin E, a potential prognostic marker for breast cancer. , 1994, Cancer research.

[33]  M. Tachibana,et al.  SCID mice: a suitable model for experimental studies of urologic malignancies. , 1991, The Journal of urology.

[34]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.